Objective: To compare differences in severity and type of EEG abnormalities between early and late onset Alzheimer's disease (AD) and to assess the influence of APOE genotype on this association, in order to understand the biological differences in AD according to age at onset Method: Of 460 probable AD patients and 336 patients with subjective complaints, serving as controls, EEG and APOE genotype were obtained. Subjects were categorised by age into a younger (≤ 65 years) and an older group (> 65 years), based on age at diagnosis. Severity and type of EEG abnormalities were visually assessed.
Introduction
Alzheimer's disease (AD) is the most common cause of dementia. Although it is typically regarded as a disease of old age, it does occur in younger patients (i.e. before the age of 65 years), commonly referred to as early onset AD. The characteristic clinical presentation of AD in the elderly consists of progressive memory impairment, followed by global cognitive decline. Early onset AD often presents in a different way compared to AD with late onset. Early onset AD patients more often show focal impairments like aphasia and apraxia,(1-4) and a more rapid cognitive decline.(5; 6) APOE ε 4 genotype is associated with age at onset. (7) Moreover, it has been suggested that APOE ε 4 carriers present with more severe memory impairment, while conversely non-carriers present with more pronounced impairment in other cognitive domains .(8; 9) These differences in presentation suggest the existence of heterogeneity within the spectrum of AD.
EEG can be used to distinguish AD patients and healthy controls, with a positive predictive value between 75-80% in visual as well as quantitative analysis. (10) Hallmarks of EEG abnormalities in AD are an increase in diffuse slow activity and a reduction in alpha and beta activities.(11) Studies on EEG in early onset AD are sparse. In a small group of early onset AD patients an increase of power in the slow frequency bands and a decrease of power in the fast frequency bands was found, compared to age-matched controls.(12) However, no comparison was made between early onset and late onset AD. In another study, correlations were found between several EEG parameters and age at onset of AD. A more 'abnormal' EEG occurred in patients with a younger age of onset. (13) In the present study we aimed to compare differences in severity and type of EEG abnormalities between early onset and late onset AD by visual EEG analysis in a large population of AD patients. A group of controls was included for comparison.
Furthermore we assessed how APOE genotype influenced this association. We hypothesized that patients with early onset AD have more often and more severe EEG abnormalities compared to patients with late onset AD. consisted of patients who presented at our memory clinic with subjective complaints, but who had normal clinical investigations and did not have significant cognitive deficits (i.e. MCI criteria were not fulfilled) or major psychiatric disorder. To rule out the influence of past medical history on EEG characteristics, we excluded 54 patients, with a past medical history of epilepsy, serious head trauma, ischemic stroke, haemorrhagic stroke, subarachnoid haemorrhage, multiple sclerosis, meningitis, encephalitis or intracranial space occupying lesions. Patients were categorised in younger (65 years or younger; n= 154) and older (older than 65 years; n=280) category, based on age at diagnosis at the multidisciplinary consensus meeting.
Methods

Subjects
Controls were also categorised in a younger (n=211) and an older (n=97) age group, based on age at time of discussion at the multidisciplinary consensus meeting. The study has been approved by the ethical review board of the VU University Medical Center. All patients gave written informed consent to use their clinical data for research purposes. These two variables were combined in a third 4-level variable: (i) no abnormalities,
(ii) only focal abnormalities, (iii) only diffuse abnormalities and (iv) both focal and diffuse abnormalities. In addition, severity of EEG abnormalities was rated using a 4-point scale, ranging from no abnormalities to severe abnormalities. Due to very small group size for severe abnormalities (n=4), the groups moderately severe and severe abnormality were merged, resulting in 3 levels in the severity variable: none, mild, moderate to severe abnormalities. In previous reports by our study group kappavalues for inter observer agreement between .60 and .87 have been reported. (15) APOE genotyping APOE genotyping was performed after DNA isolation from 10 ml EDTA blood, with the Light Cycler APOE mutation detection method (Roche Diagnostics GmbH, Mannheim, Germany). APOE ε4 carrier ship was dichotomized in negative or positive, with positive containing both homozygous and heterozygous APOE ε4 carriers. confidence intervals are reported.
Results
Baseline characteristics are presented for patients and controls according to age (table   1) . The mean age in the AD group was higher than in the control group, for both the younger and the older patients. AD patients were more often APOE ε4 positive than controls. In the group of AD patients there was no difference in sex, estimated disease duration or APOE ε4 carrier ship according to age. The younger AD group had a lower MMSE-score than the older AD group. In controls there was no difference in sex, MMSE-score or APOE ε4 carrier ship according to age. reported pulmonary disease, 3% reported a history of other psychiatric disease and 2% of AD patients reported multiple of the abovementioned. Table 2 shows the prevalence of type and severity of EEG abnormalities. Statistics are performed using Chi-square test, difference in prevalence according to age
The whole group of AD patients shows more EEG abnormalities than the controls (p < .001). Younger AD patients more often showed EEG abnormalities than older ones (p < .05), especially a combination of focal and diffuse abnormalities. Furthermore, the observed EEG abnormalities were more severe in younger patients than in older patients (p < .05). Examples of characteristic EEGs of both a younger AD patient and an older AD patient are shown in figure 1. In controls we found the opposite pattern:
EEG abnormalities were found more often in older controls than in younger controls (p < .01), although there was no significant difference in severity of abnormalities (p = .54). Figure 2 shows the association between EEG abnormalities and APOE ε4 genotype.
We observed that APOE ε4 negative AD patients had more severe EEG abnormalities than APOE ε4 positive patients (p <. 05); we found no effect of APOE ε4 genotype on type of EEG abnormalities. In controls there was no effect of APOE ε4 genotype on type or severity of EEG abnormalities.
Subsequently, we used logistic regression to adjust for sex, use of psychotropic medication and estimated disease duration (see table 3 ). 
Discussion
We found that younger AD patients more often had a combination of focal and diffuse EEG abnormalities than older AD patients. They also had more severe EEG abnormalities than older AD patients. In controls, the opposite effect was found: more often and more severe EEG abnormalities occurred in older controls. In APOE ε4
negative AD patients severe EEG abnormalities occurred more often than in APOE ε4 positive patients. This effect was independent of the effect of age.
Our results are in line with the few earlier studies that reported more severe EEG abnormalities in early onset AD. In a quantitative EEG study on patients with early onset AD opposed to controls, early onset AD patients showed an increase of power in the slow frequency bands. (12) In a study comparing early onset AD patients with late onset AD patients, significant correlations were found between age at onset and relative power in different frequency bands.(13) We extend on these former studies by including a large sample of AD patients and controls, showing that the effect of age on EEG has opposite directions in these two groups.
Earlier research on the difference between early onset and late onset AD showed evidence of heterogeneity in other modalities as well: early onset AD patients show more global atrophy with a faster atrophy rate, (17) Strengths of this study are the large cohort size including AD patients as well as controls with a wide age range, and the use of visual analysis, which together make the findings in our study quite robust. Visual analysis is a relatively easy and fast way of analysing EEG's and, for clinical purposes, the visual assessment of EEG is equal to quantitative analysis, with a high sensitivity for moderate-to-severe dementia. (25) A former study demonstrated that visual EEG analysis can be used to differentiate between different diagnoses in a memory clinic population.(15) Another tool for visual EEG analysis, the Grand Total of EEG (GTE) score, has proven to be useful in the diagnostic evaluation of AD (26) and in differentiating between DLB and AD with good sensitivity and specificity. (27) In the present study, we show that visual analysis can also differentiate subgroups within the spectrum of AD.
A possible limitation of this study is the use of patients with subjective complaints as control group, since these patients are known to have an increased risk of progression to dementia (28) and could comprise of a complex group. However, we believe that by excluding patients with major psychiatric disorders, our control group is generalizable to a normal population.
The results of this study give further evidence for the existence of biological differences between early onset and late onset AD. We demonstrated that early onset AD patients show more EEG abnormalities than late onset AD patients. This implies that early onset AD patients behave differently than late onset patients not only on a structural, behavioural and cognitive level, but also on the level of brain function. An underlying structural and functional difference in different patient groups within AD is of great clinical importance, since it can help making an early diagnosis, it can influence the kind of treatment needed and it might imply a different prognosis. 
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